Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

• Päätekijät: Chunlu Li (Tekijä), Xiaoxuan Li (Tekijä), Feihong Huang (Tekijä), Jing Yang (Tekijä), Anguo Wu (Tekijä), Long Wang (Tekijä), Dalian Qin (Tekijä), Wenjun Zou (Tekijä), Jianming Wu (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2019-07-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Avatrombopag is a novel oral, nonpeptide thrombopoietin receptor agonist (TPO-RA). A few studies have shown that avatrombopag is effective against thrombocytopenia. However, no systematic review has been conducted on the efficacy and safety of avatrombopag. Therefore, the aim of this stu...